296 related articles for article (PubMed ID: 12538724)
1. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses.
Anjuère F; George-Chandy A; Audant F; Rousseau D; Holmgren J; Czerkinsky C
J Immunol; 2003 Feb; 170(3):1586-92. PubMed ID: 12538724
[TBL] [Abstract][Full Text] [Related]
2. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development.
Eriksson K; Fredriksson M; Nordström I; Holmgren J
Infect Immun; 2003 Apr; 71(4):1740-7. PubMed ID: 12654787
[TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin.
Luci C; Hervouet C; Rousseau D; Holmgren J; Czerkinsky C; Anjuère F
J Immunol; 2006 Mar; 176(5):2749-57. PubMed ID: 16493030
[TBL] [Abstract][Full Text] [Related]
4. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice.
Rask C; Holmgren J; Fredriksson M; Lindblad M; Nordström I; Sun JB; Czerkinsky C
Clin Exp Allergy; 2000 Jul; 30(7):1024-32. PubMed ID: 10848926
[TBL] [Abstract][Full Text] [Related]
5. Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.
Wiedermann U; Jahn-Schmid B; Lindblad M; Rask C; Holmgren J; Kraft D; Ebner C
Int Immunol; 1999 Jul; 11(7):1131-8. PubMed ID: 10383946
[TBL] [Abstract][Full Text] [Related]
6. Modulation of an allergic immune response via the mucosal route in a murine model of inhalative type-I allergy.
Wiedermann U; Jahn-Schmid B; Repa A; Kraft D; Ebner C
Int Arch Allergy Immunol; 1999; 118(2-4):129-32. PubMed ID: 10224359
[TBL] [Abstract][Full Text] [Related]
7. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
8. Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin.
Tamura S; Shoji Y; Hasiguchi K; Aizawa C; Kurata T
Vaccine; 1994 Oct; 12(13):1238-40. PubMed ID: 7839730
[TBL] [Abstract][Full Text] [Related]
9. Cholera toxin promotes the induction of regulatory T cells specific for bystander antigens by modulating dendritic cell activation.
Lavelle EC; McNeela E; Armstrong ME; Leavy O; Higgins SC; Mills KH
J Immunol; 2003 Sep; 171(5):2384-92. PubMed ID: 12928385
[TBL] [Abstract][Full Text] [Related]
10. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
Zhang P; Lewis JP; Michalek SM; Katz J
Vaccine; 2007 Aug; 25(33):6201-10. PubMed ID: 17629367
[TBL] [Abstract][Full Text] [Related]
11. Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28.
Ryan M; McCarthy L; Rappuoli R; Mahon BP; Mills KH
Int Immunol; 1998 May; 10(5):651-62. PubMed ID: 9645613
[TBL] [Abstract][Full Text] [Related]
12. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization.
de Geus B; Dol-Bosman M; Scholten JW; Stok W; Bianchi A
Vaccine; 1997 Jul; 15(10):1110-3. PubMed ID: 9269054
[TBL] [Abstract][Full Text] [Related]
13. The Nontoxic Cholera B Subunit Is a Potent Adjuvant for Intradermal DC-Targeted Vaccination.
Antonio-Herrera L; Badillo-Godinez O; Medina-Contreras O; Tepale-Segura A; García-Lozano A; Gutierrez-Xicotencatl L; Soldevila G; Esquivel-Guadarrama FR; Idoyaga J; Bonifaz LC
Front Immunol; 2018; 9():2212. PubMed ID: 30319653
[TBL] [Abstract][Full Text] [Related]
14. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.
Glenn GM; Scharton-Kersten T; Vassell R; Matyas GR; Alving CR
Infect Immun; 1999 Mar; 67(3):1100-6. PubMed ID: 10024549
[TBL] [Abstract][Full Text] [Related]
15. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice.
Van der Heijden PJ; Bianchi AT; Dol M; Pals JW; Stok W; Bokhout BA
Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237
[TBL] [Abstract][Full Text] [Related]
16. Intradermal immunization in the ear with cholera toxin and its non-toxic β subunit promotes efficient Th1 and Th17 differentiation dependent on migrating DCs.
Meza-Sánchez D; Pérez-Montesinos G; Sánchez-García J; Moreno J; Bonifaz LC
Eur J Immunol; 2011 Oct; 41(10):2894-904. PubMed ID: 21792876
[TBL] [Abstract][Full Text] [Related]
17. Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract.
Yoshikawa T; Uchida T; Naito S; Horino A; Taneichi M; Kato H; Komuro K; Nakano Y; Mori M; Nishinohara S; Chiba J; Kurata T; Tamura S
Int Arch Allergy Immunol; 2000 Feb; 121(2):108-15. PubMed ID: 10705220
[TBL] [Abstract][Full Text] [Related]
18. Nasally administered cholera toxin A-subunit acts as a mucosal adjuvant.
Campos EA; Namikoshi J; Maeba S; Yamamoto M; Fukumoto M; Yamamoto H
J Oral Sci; 2003 Mar; 45(1):25-31. PubMed ID: 12816361
[TBL] [Abstract][Full Text] [Related]
19. Oral tolerance revisited: prior oral tolerization abrogates cholera toxin-induced mucosal IgA responses.
Kato H; Fujihashi K; Kato R; Yuki Y; McGhee JR
J Immunol; 2001 Mar; 166(5):3114-21. PubMed ID: 11207263
[TBL] [Abstract][Full Text] [Related]
20. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen.
Wiedermann U; Jahn-Schmid B; Fritsch R; Bauer L; Renz H; Kraft D; Ebner C
Clin Exp Immunol; 1998 Jan; 111(1):144-51. PubMed ID: 9472674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
